Anti-Inflammatory Treatment of Schizophrenia
NCT01514682
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Schizophrenia
Interventions
DRUG:
Anti-inflammatory Combination Therapy
DRUG:
Placebo
Sponsor
University of Maryland, Baltimore